olivLaw · US equity research
Ispire Technology Inc. ISPR
Cigarettes · SIC 2111 · Vertical: Cigarettes (SIC 2111)
Ispire Technology Inc. designs, manufactures and sells vaping devices, marketed under the Aspire brand for nicotine and cannabis hardware built on its own heating technologies and factories in Malaysia. The company is emerging from a difficult year, with revenue falling to 96 million dollars in fiscal 2026, yet it reports a better fourth quarter and smaller losses, and investors are watching whether its new programs can restore growth.
At the close of 04 Nov 2026, Ispire Technology Inc. (ISPR) stock was 1.50 USD (−4.46% on the day), with market capitalisation 86.6 m USD, beta 0.98, 52-week range 1.10–3.68 USD. Latest reported quarter (Q4 2026): revenue of 26.7 m USD (+32.5% YoY), net income of -13.8 m USD, diluted EPS -0.24 USD.
Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.
Price history
Loading chart…
Technical reading
- RSI (14)
- 57.3
- strong (55–70)
- Bollinger (20, 2)
- 1.28 – 1.55
- in the upper half of the band · %B 0.83 · band width 18.8%
- SMA 50 / 200
- 1.40 / 1.81
- mixed trend
- MACD (12, 26, 9)
- 0.02 / 0.00
- MACD above signal
Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).
Performance
| Company | S&P 500 | vs S&P 500 | Vertical median | |
|---|---|---|---|---|
| 1 month | +15.4% | −1.1% | +16.5 pp | — |
| 3 months | −5.7% | −0.5% | −5.2 pp | — |
| 6 months | −10.7% | +4.4% | −15.1 pp | — |
| Year to date | −45.8% | +12.3% | −58.2 pp | — |
| 1 year | −9.6% | +13.5% | −23.2 pp | +7.3% |
| 3 years | −81.9% | +76.4% | −158.3 pp | +85.6% |
| 5 years | unavailable | +63.7% | unavailable | — |
Price returns, dividends excluded.
Quarterly results
Latest quarter: Q4 2026 · 30 Jun 2026
Quarterly margins
Quarterly statements · USD
| Fiscal year | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 39.3 m | 41.8 m | 26.2 m | 20.1 m | 30.4 m | 20.3 m | 18.7 m | 26.7 m |
| Cost of revenue | 31.7 m | 34.1 m | 21.4 m | 17.7 m | 25.2 m | 16.8 m | 16.7 m | 25.0 m |
| Gross profit | 7.7 m | 7.7 m | 4.8 m | 2.5 m | 5.1 m | 3.5 m | 2.0 m | 1.7 m |
| Operating income | -5.3 m | -7.4 m | -10.6 m | -14.6 m | -2.7 m | -6.9 m | -9.5 m | -13.5 m |
| Depreciation & amortisation | 204.8 k | 188.5 k ≈ | 199.0 k ≈ | 220.2 k | 253.4 k | 227.8 k ≈ | 210.7 k ≈ | 253.1 k |
| Interest expense | 11.5 k | 13.1 k | 35.6 k | 128.6 k | 112.2 k | 100.2 k | 87.2 k | 74.6 k |
| Pre-tax income | -5.1 m | -7.5 m | -10.7 m | -14.7 m | -2.8 m | -6.5 m | -9.3 m | -13.4 m |
| Income tax | 456.8 k | 460.0 k | 177.0 k | 109.9 k | 486.1 k | 106.6 k | 177.4 k | 377.3 k |
| Net income | -5.6 m | -8.0 m | -10.9 m | -14.8 m | -3.3 m | -6.6 m | -9.5 m | -13.8 m |
| Diluted EPS | -0.10 | -0.14 | -0.19 | -0.26 ≈ | -0.06 | -0.12 | -0.17 | -0.24 ≈ |
| Operating cash flow | 3.6 m | -3.2 m ≈ | -12.5 m ≈ | 4.7 m | -1.2 m | -4.0 m ≈ | 2.0 m ≈ | 2.6 m |
| Capex | 268.8 k | 54.0 k ≈ | -181.8 k ≈ | 959.7 k | 7.5 k | 69.4 k ≈ | 247.3 k ≈ | -18.3 k |
| Share repurchases | — | — | — | 0 | — | — | 0 ≈ | 0 |
≈ derived quarter (cumulative difference / share-days average)
E/P over time
E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.
Fiscal years
| Fiscal year | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Revenue | 88.1 m | 115.6 m | 151.9 m | 127.5 m | 96.0 m |
| Revenue YoY | unavailable | +31.2% | +31.4% | −16.1% | −24.7% |
| Net income | -1.9 m | -6.0 m | -14.8 m | -39.2 m | -33.2 m |
| Net income YoY | unavailable | unavailable | unavailable | unavailable | unavailable |
| Diluted EPS | -0.04 | -0.12 | -0.27 | -0.69 | -0.58 |
| Diluted EPS YoY | unavailable | unavailable | unavailable | unavailable | unavailable |
| net % | -2.1% | -5.2% | -9.7% | -30.8% | -34.6% |
| Free cash flow | -7.7 m | -9.5 m | -20.3 m | -8.5 m | -875.4 k |
Reported results vs expectations
Loading…
Balance sheet & financial health
Fiscal year 2026 · 30 Jun 2026
- Cash
- 19.3 m USD
- Financial debt
- unavailable USD
- Net debt
- unavailable USD
- Equity
- -29.2 m USD
- Total assets
- 64.3 m USD
- Debt / equity
- unavailable
- Current ratio
- 1.02x
- ROE
- unavailable
- ROA
- -39.9%
- FCF margin
- -0.9%
Financial statements (source on every figure)
Revenue and net income (USD)
Margins
Income statement · USD
| Line | 2022 | 2023 | 2024 | 2025 | 2026 | Source (latest year) |
|---|---|---|---|---|---|---|
| Revenue | 88.1 m | 115.6 m | 151.9 m | 127.5 m | 96.0 m | SEC (XBRL)· 15 Sept 2026verified |
| Cost of revenue | 74.8 m | 94.8 m | 122.1 m | 104.8 m | 83.7 m | SEC (XBRL)· 15 Sept 2026verified |
| Gross profit | 13.3 m | 20.8 m | 29.8 m | 22.6 m | 12.3 m | SEC (XBRL)· 15 Sept 2026verified |
| Research & development | — | 146.1 k | 779.2 k | 363.3 k | 81.0 k | SEC (XBRL)· 15 Sept 2026verified |
| Operating income | -988.7 k | -4.5 m | -13.9 m | -37.8 m | -32.6 m | SEC (XBRL)· 15 Sept 2026verified |
| Depreciation & amortisation | 10.4 k | 46.7 k | 505.7 k | 812.5 k | 945.0 k | SEC (XBRL)· 15 Sept 2026verified |
| EBITDA | -978.3 k ≈ | -4.4 m ≈ | -13.4 m ≈ | -37.0 m ≈ | -31.6 m ≈ | SEC (XBRL)· 15 Sept 2026derived |
| Interest expense | — | 3.3 m | — | 188.8 k | 374.2 k | SEC (XBRL)· 15 Sept 2026verified |
| Pre-tax income | -803.1 k | -4.8 m | -13.5 m | -38.0 m | -32.1 m | SEC (XBRL)· 15 Sept 2026verified |
| Income tax | — | 1.2 m | 1.3 m | 1.2 m | 1.1 m | SEC (XBRL)· 15 Sept 2026verified |
| Net income | -1.9 m | -6.0 m | -14.8 m | -39.2 m | -33.2 m | SEC (XBRL)· 15 Sept 2026verified |
| Diluted EPS | -0.04 | -0.12 | -0.27 | -0.69 | -0.58 | SEC (XBRL)· 15 Sept 2026verified |
| Weighted average diluted shares | 50.0 m | 50.7 m | 54.8 m | 56.9 m | 57.3 m | SEC (XBRL)· 15 Sept 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Operating income + Depreciation & amortisation.
Balance sheet · USD
| Line | 2022 | 2023 | 2024 | 2025 | 2026 | Source (latest year) |
|---|---|---|---|---|---|---|
| Cash | 74.5 m | 40.3 m | 35.1 m | 24.4 m | 19.3 m | SEC (XBRL)· 15 Sept 2026verified |
| Receivables | 8.3 m | 24.5 m | 59.7 m | 39.6 m | 19.8 m | SEC (XBRL)· 15 Sept 2026verified |
| Inventories | 14.6 m | 7.5 m | 6.4 m | 6.6 m | 3.1 m | SEC (XBRL)· 15 Sept 2026verified |
| Current assets | 99.4 m | 84.8 m | 102.6 m | 72.9 m | 45.4 m | SEC (XBRL)· 15 Sept 2026verified |
| Property, plant & equipment, net | 1.1 m | 1.1 m | 2.6 m | 3.0 m | 2.4 m | SEC (XBRL)· 15 Sept 2026verified |
| Intangibles (excl. goodwill) | — | — | 1.4 m | 2.2 m | 2.6 m | SEC (XBRL)· 15 Sept 2026verified |
| Total assets | 100.7 m | 90.4 m | 122.6 m | 102.2 m | 64.3 m | SEC (XBRL)· 15 Sept 2026verified |
| Accounts payable | 290.5 k | 1.3 m | 3.8 m | 4.2 m | 5.7 m | SEC (XBRL)· 15 Sept 2026verified |
| Current liabilities | 89.0 m | 55.9 m | 86.0 m | 72.5 m | 44.6 m | SEC (XBRL)· 15 Sept 2026verified |
| Total liabilities | 89.0 m | 58.9 m | 88.2 m | 101.6 m | 93.5 m | SEC (XBRL)· 15 Sept 2026verified |
| Equity | 11.8 m † | 31.5 m † | 34.5 m † | 604.7 k † | -29.2 m † | SEC (XBRL)· 15 Sept 2026verified |
† equity attributable to the parent's shareholders: in these years the issuer no longer reports the total including non-controlling interests.
Cash flow · USD
| Line | 2022 | 2023 | 2024 | 2025 | 2026 | Source (latest year) |
|---|---|---|---|---|---|---|
| Operating cash flow | -7.6 m | -8.5 m | -18.3 m | -7.4 m | -569.4 k | SEC (XBRL)· 15 Sept 2026verified |
| Capex | 121.5 k | 1.0 m | 2.0 m | 1.1 m | 306.0 k | SEC (XBRL)· 15 Sept 2026verified |
| Free cash flow | -7.7 m ≈ | -9.5 m ≈ | -20.3 m ≈ | -8.5 m ≈ | -875.4 k ≈ | SEC (XBRL)· 15 Sept 2026derived |
| Investing cash flow | -121.5 k | -10.2 m | 3.0 m | -5.2 m | -3.1 m | SEC (XBRL)· 15 Sept 2026verified |
| Financing cash flow | -3.1 m | -15.6 m | 10.1 m | 1.9 m | -1.3 m | SEC (XBRL)· 15 Sept 2026verified |
| Dividends paid | 469.6 k | 3.4 m | — | — | — | SEC (XBRL)· 19 Sept 2023verified |
| Share repurchases | — | — | — | 60.5 k | 45.0 k | SEC (XBRL)· 15 Sept 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Operating cash flow − Capex.
Computed indicators
Growth
Profitability
Returns
Balance sheet
Liquidity
Cash
Efficiency
Market and valuation
1 indicators that do not apply to the sector.
Valuation
olivLaw classification
- score weight coverage: 39.6% of at least 60%
- valuation methods computed: 0 of at least 1
A scoring methodology on indicators and valuation, not investment advice.
Closing price
04 Nov 2026Source: olivLaw, closing series
Market cap: 86.6 m USD
Key indicators
Coverage and freshness
Score by group
40% · Insufficient data
Estimated value range
unavailable — no valuation method could be computed
Valuation assumptions are editorial choices, not measured; beta is not measured.
Valuation methods
- DCF (discounted cash flow)unavailable · net debt missing: EV cannot be bridged to equity (missing debt is not zero)
- Peers: EV/EBITDAunavailable · net debt missing: EV cannot be bridged to equity (missing debt is not zero)
- Peers: P/Eunavailable · the base of the ratio is not positive
- Dividend discount (DDM)unavailable · input data missing
no valuation method could be computed
Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.
Assumptions (illustrative, editorial)
- Risk-free rate
- 4.3%
- Equity risk premium
- 5.0%
- Beta (default)
- 1.00
- Cost of equity
- 9.3%
- Terminal growth
- 2.5%
Factor scorecard
Insufficient data
Minimum-evidence gate: score weight coverage: 39.6% of at least 60%; valuation methods computed: 0 of at least 1
| Factor | Value | Score | Weight used |
|---|---|---|---|
| ROIC · Quality | unavailable | unavailable | — |
| Net margin · Quality | -34.6% | 0 (vs peers) | 16% |
| FCF conversion · Quality | unavailable | unavailable | — |
| Revenue CAGR 3Y · Growth | -6.0% | 0 (on a fixed band) | 21% |
| EPS CAGR 3Y · Growth | unavailable | unavailable | — |
| Net debt / EBITDA · Balance sheet | unavailable | unavailable | — |
| Interest coverage · Balance sheet | -87.1x | 0 (on a fixed band) | 16% |
| Current ratio · Balance sheet | 1.0x | 18 (on a fixed band) | 11% |
| P/E (TTM) · Valuation | unavailable | unavailable | — |
| EV/EBITDA · Valuation | unavailable | unavailable | — |
| FCF yield · Valuation | -1.0% | 0 (on a fixed band) | 21% |
| Shareholder yield (distributions) · Returns | 0.1% | 1 (on a fixed band) | 16% |
| Payout ratio (FCF) · Returns | unavailable | unavailable | — |
Factors without a value were dropped; the remaining weights were renormalised.
Score groups
- Balance sheet7/100 · 2/3 factors with a value
- Growth· partial0/100 · 1/2 factors with a value
- Quality· partial0/100 · 1/3 factors with a value
- Returns· partial1/100 · 1/2 factors with a value
- Valuation· partial0/100 · 1/3 factors with a value
A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.
Memo
Ispire Technology Inc. (ISPR). Latest full fiscal year: 2026; data up to 2026-06-30.
Figures computed from the financial statements: revenue 96.0 m USD in 2026; YoY growth -24.7%; net margin -34.6%.
Valuation cannot be computed from the available data.
Insufficient data for a verdict (score weight coverage: 39.6% of at least 60%; valuation methods computed: 0 of at least 1).
Text generated deterministically from the figures shown; no language model. Not investment advice.
What supports the thesis
No signal among the computed factors. That is not an absence of risk: factors without data were not assessed, and business risks (margins, inventory, demand) are in the source-based analysis.
What contradicts it
- Net margin: -34.6%
- Revenue CAGR 3Y: -6.0%
- Interest coverage: -87.1x
- Current ratio: 1.0x
- FCF yield: -1.0%
- Shareholder yield (distributions): 0.1%
Not assessed (insufficient data or a ratio without meaning): ROIC, FCF conversion, EPS CAGR 3Y, Net debt / EBITDA, P/E (TTM), EV/EBITDA, Payout ratio (FCF).
Versus the vertical median
Cigarettes (SIC 2111) · same industry (4-digit SIC) · compared with 5 companies
Multiples and returns vs the median
Price rebased to 100 (monthly, 5 years)
Companies in the vertical
| Market cap | P/E | ROE | Net margin | Revenue YoY | 1A / 3A | |
|---|---|---|---|---|---|---|
| PMPhilip Morris International Inc. | 329.3 bn | 30.8 | — | 24.8% | +7.3% | +34% / +126% |
| MOAltria Group, Inc. | 129.8 bn | 16.1 | — | 34.5% | −3.1% | +32% / +86% |
| RLXRLX Technology Inc. | 2.5 bn | 16.4 | 6.0% | 23.3% | +50.3% | −35% / −27% |
| ISPRIspire Technology Inc. | 86.6 m | — | — | -34.6% | −24.7% | −10% / −82% |
| XXII22nd Century Group, Inc. | 30.0 k | — | -32.4% | -27.0% | −27.9% | −100% / −100% |
| BTIBritish American Tobacco p.l.c. | — | — | 16.5% | 30.3% | −1.0% | +7% / +97% |
1- and 3-year price returns: for ISPR from daily closes (the same as the performance table), for the other companies from month-end closes.
olivLaw engine forecast
The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.
The engine has no published run for this company yet.
Valuation scenarios (editable assumptions)
Illustrative scenarios
Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.
Estimated price (USD)
| Estimated price | Bear | Base | Bull |
|---|---|---|---|
| 1 years | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable |
| 3 years | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable |
| 5 years | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable |
AI analysis
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
In brief
Ispire Technology Inc. designs, manufactures and sells vaping devices, marketed under the Aspire brand for nicotine and cannabis hardware built on its own heating technologies and factories in Malaysia. The company is emerging from a difficult year, with revenue falling to 96 million dollars in fiscal 2026, yet it reports a better fourth quarter and smaller losses, and investors are watching whether its new programs can restore growth.
SWOT
Strengths
- The company has a broad global distribution base and a portfolio of technology patents, including heating technologies and cannabis designs.
- The Malaysian factory holds ISO certifications and a final production license for nicotine products, which may support access to regulated markets.
- Cash flow from operations improved quarter over quarter and came close to balance, which could ease financing pressure.
Weaknesses
- The company reported net losses in both of its recent fiscal years and cannot guarantee future profitability.
- Reliance on a supplier controlled by the chief executive officer creates conflicts of interest and contract risks.
- Receivables remain large and credit losses stayed high, which weighs on liquidity.
Opportunities
- If the Malaysian factory runs fully, the company could produce for more customers and reduce reliance on third parties.
- ODM programs and age-verification technology could open new revenue if they win large brand customers.
- G-Mesh technology could attract licenses from large tobacco companies if talks reach agreement.
Threats
- Vaping rules can change quickly and may restrict sales in several countries.
- Federal rescheduling of cannabis in the US could impose new rules on cannabis hardware.
- Competitive pressure on prices could further reduce gross margin.
Risks
- Recurring losseshigh
The company cannot assure that it will become profitable, having posted net losses in recent fiscal years.
- Control by the chief executive officerhigh
The chief executive officer and his wife control most shares and hold decisive influence over the company.
- Affiliated supplierhigh
Most products come from a supplier owned by the chief executive officer, creating price and contract risks.
- Vaping regulationmedium
Restrictions on nicotine and flavors could limit sales in several major markets.
- Receivables collectionmedium
The risk of customer non-payment remains high and could lead to further receivable losses.
Investment thesis
What would need to be true (bull case)
- If the Malaysian factory and ODM programs scale up, the company could return to growth and positive cash flow.
- Age-verification and G-Mesh technologies could generate significant licensing or revenue over the long term.
- The quarterly trend toward smaller losses and better sales in the fourth quarter could indicate a turnaround.
What would break the thesis
- If sales in Europe and the US do not recover, losses could continue and the company could need additional funding.
- The conflict of interest with the main supplier could weigh on margins and strategic decisions.
- Rules for vaping and cannabis could tighten quickly, which could limit existing markets.
What to watch
- Operating cash flow and liquidity after the Malaysian factory investmentsQ1 2027
- ODM contracts with large brands and launch of age-verification products through IKE Tech2027
- DEA decision on cannabis rescheduling and its effect on hardware sales2027
- Outcome of G-Mesh licensing talks and trend in credit lossesnext 10-K
Products, market & competition
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
The business
Ispire designs and distributes vaping devices, including e-cigarettes sold under the Aspire brand in more than 30 countries through over 100 distributors, excluding the US, China and Russia 1. For cannabis, it sells hardware under the Ispire brand, mainly on an original design manufacturer basis for other companies, chiefly in the US, Canada and South Africa 1. The company has three operating subsidiaries in California, Malaysia and Hong Kong, and most products are made by Shenzhen Yi Jia, which is 95% owned by the chief executive officer and controlling shareholder, a documented conflict of interest 1.
The Malaysian factory began manufacturing in February 2024 and received full licensure in March 2026, but its current work focuses on assembling components bought from third parties 1. The company has also launched the Ispire ONE technology for sealed filling of cartridges and devices, and the G-Mesh technology marketed under the Silica Series brand 1. Through its joint venture with Touch Point Worldwide and Chemular, Ispire is pursuing age-verification technologies and expansion into the nicotine pouch market 2.
Funding has come from three rounds since the April 2023 IPO, including a March 2024 public offering at 6 dollars per share whose proceeds went to the Malaysian factory and the joint venture 1. The company restructured during 2025 and 2026, cutting staff and operating costs in North America 1.
Segments
Nicotine (Aspire)
Nicotine vaping devices sold under the Aspire brand are the main revenue source, particularly in Europe, which accounted for 63.9% of revenue in fiscal 2026 1. European sales fell from 74.1 million to 61.4 million dollars, reflecting regulatory uncertainty over disposable bans and flavor restrictions 1.
Market context
The global vaping market is regulated differently from country to country, from limited rules to outright bans, and the rules can change quickly 1. The company cites a global vape market of about 73 billion dollars and a 25% tariff advantage over China for exports to the US from Malaysia 2. Cannabis remains legal in the US only at state level, and a pending federal rescheduling could change the conditions for cannabis hardware 1.
Trends
- Vaping regulation in Europeheadwind
Uncertainty over disposable bans and flavor restrictions made distributors cautious in purchasing, reducing European sales 1.
- Federal cannabis rescheduling in the USmixed
If the DEA adopts rescheduling of cannabis to Schedule III, new compliance obligations could apply to US operators and could affect sales of cannabis hardware 1.
- Malaysian production and tariffstailwind
The Malaysian factory and the tariff advantage over China for US exports could support growth if production scales up, though costs and operating risks remain 2.
- Price pressureheadwind
Competitive pressure lowered selling prices on some products and contributed to the decline in gross margin 1.
Competitive position
Ispire operates in a market with many vaping manufacturers, and the company names competitive pricing pressure as a factor in its lower gross margin 1. The source documents do not name other direct competitors, so the competitive picture cannot be detailed further from them 1.
The company also competes on technology, patents and the ability to enter regulated markets, so success depends on innovation and compliance 2. Ispire could benefit from its own factory and ODM model if it offers competitive production 2.
- Third-party vaping hardware makers
Unnamed competitors in the sources that offer lower prices and can influence Ispire's margin.
- Shenzhen Yi Jia
Main supplier, but also an affiliate controlled by the chief executive officer, so not a conventional competitor.
- Distributors and ODM brands
ODM customers could become competitors if they make cannabis hardware in-house.
- Tobacco companies with nicotine products
The company notes interest from large tobacco companies in G-Mesh technology, indicating both competition and possible partnerships.
Links, dependencies and risks
Who the company is tied to, from its own SEC filings (customers, suppliers, production, partners, competitors, countries, regulation), from the 5 %+ holders' statements (13D/13G) and from what other companies say about it. Click a node for its evidence; on a listed company the graph moves to it.
Loading the links…
News & filings
In the press
- Hyrox and Xenom aspire to make fitness 'largest sport on earth'CNA (Channel NewsAsia) · 23 Oct 2026 · EN
- Why the Hilton Aspire is still my favorite hotel credit card after more than 5 yearsThe Points Guy · 13 Oct 2026 · EN
- Aspire 13.6 Adds Persistent Dashboard Telemetry and First-Party Java and Rust HostingInfoQ · 05 Oct 2026 · EN
- Hilton Honors American Express Aspire Card review: A card for all Hilton fansThe Points Guy · 24 Sept 2026 · EN
- POLITEHNICA București, EVANTAGE Soft și Renault Group dezvoltă un parteneriat strategic pentru cercetare și inovare în inteligența artificială pentru industria auto și lansează laboratorul ASPIREFinancial Intelligence (RO) · 23 Sept 2026 · RO
- Femeile care au practicat sport în adolescență sunt mai predispuse să aspire la poziții de conducere, potrivit unui studiuMediafax · 20 Sept 2026 · RO
- Ispire (ISPR) Q4 2026 Earnings Call TranscriptYahoo Finance — News · 17 Sept 2026 · EN
- Ispire Technology Inc. Q4 2026 Earnings Call SummaryYahoo Finance — News · 16 Sept 2026 · EN
- Ispire Technology Q4 Earnings Call HighlightsYahoo Finance — News · 16 Sept 2026 · EN
- Aspiratorul robot în 2026: încă un gadget sau primul pas către o casă care se întreține singură? 5 modele care fac mai mult decât să aspire + Bonus surprizăAdevărul · 10 Sept 2026 · RO
- NVIDIA AI Introduces ASPIRE: A Self-Improving Robotics Framework Reaching 31% Zero-Shot on LIBERO-Pro Long TasksMarkTechPost (Asia AI) · 04 Jul 2026 · RO
- TypeScript devs no longer need to tangle with C# to use Aspire dev stack after Microsoft updateThe Register · 03 Jun 2026 · RO
SEC filings
- Current report23 Sept 2026Regulation FD disclosure · Financial statements and exhibits
- Current report17 Sept 2026Results of operations · Regulation FD disclosure · Financial statements and exhibits
- Annual report15 Sept 2026
- Current report17 Aug 2026Departure or appointment of officers · Regulation FD disclosure · Financial statements and exhibits
- Current report17 Jul 2026Departure or appointment of officers
- Current report25 Jun 2026Shareholder vote
- Proxy statement12 May 2026
- Quarterly report07 May 2026
- Quarterly report06 Feb 2026
- Quarterly report06 Nov 2025
Sources
- [1] Form 10-K, fiscal year ended 2026-06-30 · SEC / Ispire Technology Inc. · 15 Sept 2026
- [2] Form 8-K, results release (exhibit 99.1) · SEC / Ispire Technology Inc. · 17 Sept 2026
Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.